Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission

Also known as: Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB01254Dasatinib1Terminated1
DB00619Imatinib1Terminated1
DB04868Nilotinib1Terminated1
DB08877Ruxolitinib1Terminated1
DB00531Cyclophosphamide1 / 2Active Not Recruiting1
DB01073Fludarabine1 / 2Active Not Recruiting1
DB01042Melphalan1 / 2Active Not Recruiting1
DB00688Mycophenolate mofetil1 / 2Active Not Recruiting1
DB00877Sirolimus1 / 2Active Not Recruiting1
DB06616Bosutinib2Recruiting1
DB01254Dasatinib2Recruiting1
DB00619Imatinib2Recruiting1
DB04868Nilotinib2Recruiting1